UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 200

Sortiert nach

N-acetylaspartylglutamate (NAAG) and glutamate carboxypeptidase II: An abundant peptide neurotransmitter-enzyme system with multiple clinical applications

Progress in neurobiology, 2020-01, Vol.184, p.101722, Article 101722

2020

Link zum Volltext

Verfügbarkeit prüfen

Mice lacking glutamate carboxypeptidase II develop normally, but are less susceptible to traumatic brain injury

Journal of neurochemistry, 2015-07, Vol.134 (2), p.340-353

2015

Link zum Volltext

Verfügbarkeit prüfen

Advances in understanding the peptide neurotransmitter NAAG and appearance of a new member of the NAAG neuropeptide family

Journal of neurochemistry, 2011-08, Vol.118 (4), p.490-498

2011

Link zum Volltext

Verfügbarkeit prüfen

Endogenous N-Acetylaspartylglutamate (NAAG) Inhibits Synaptic Plasticity/Transmission in the Amygdala in a Mouse Inflammatory Pain Model

Molecular pain, 2010-09, Vol.6 (1), p.60-60

2010

Link zum Volltext

Verfügbarkeit prüfen

Parkin-mediated reduction of nuclear and soluble TDP-43 reverses behavioral decline in symptomatic mice

Human molecular genetics, 2014-09, Vol.23 (18), p.4960-4969

2014

Link zum Volltext

Verfügbarkeit prüfen

Effects of N-Acetylaspartylglutamate (NAAG) Peptidase Inhibition on Release of Glutamate and Dopamine in Prefrontal Cortex and Nucleus Accumbens in Phencyclidine Model of Schizophrenia

The Journal of biological chemistry, 2012-06, Vol.287 (26), p.21773-21782

2012

Link zum Volltext

Verfügbarkeit prüfen

A role for N-acetylaspartylglutamate (NAAG) and mGluR3 in cognition

Neurobiology of learning and memory, 2019-02, Vol.158, p.9-13

2019

Link zum Volltext

Verfügbarkeit prüfen

N‐Acetylaspartylglutamate is an agonist at mGluR3 in vivo and in vitro

Journal of neurochemistry, 2011-12, Vol.119 (5), p.891-895

Neale, Joseph H.

2011

Link zum Volltext

Verfügbarkeit prüfen

Synthesis of Urea-Based Inhibitors as Active Site Probes of Glutamate Carboxypeptidase II: Efficacy as Analgesic Agents

Journal of medicinal chemistry, 2004-03, Vol.47 (7), p.1729-1738

2004

Link zum Volltext

Verfügbarkeit prüfen

A role for the locus coeruleus in the analgesic efficacy of N-acetylaspartylglutamate peptidase (GCPII) inhibitors ZJ43 and 2-PMPA

Molecular pain, 2017, Vol.13, p.1744806917697008

2017

Link zum Volltext

Verfügbarkeit prüfen

Design of Remarkably Simple, Yet Potent Urea-Based Inhibitors of Glutamate Carboxypeptidase II (NAALADase)

Journal of medicinal chemistry, 2001-02, Vol.44 (3), p.298-301

2001

Link zum Volltext

Verfügbarkeit prüfen

NAAG peptidase inhibitor increases dialysate NAAG and reduces glutamate, aspartate and GABA levels in the dorsal hippocampus following fluid percussion injury in the rat

Journal of neurochemistry, 2006-05, Vol.97 (4), p.1015-1025

2006

Link zum Volltext

Verfügbarkeit prüfen

Antinociceptive effects of N-acetylaspartylglutamate (NAAG) peptidase inhibitors ZJ-11, ZJ-17 and ZJ-43 in the rat formalin test and in the rat neuropathic pain model

The European journal of neuroscience, 2004-07, Vol.20 (2), p.483-494

2004

Link zum Volltext

Verfügbarkeit prüfen

Intracerebroventricular Administration of N-Acetylaspartylglutamate (NAAG) Peptidase Inhibitors is Analgesic in Inflammatory Pain

Molecular pain, 2008-08, Vol.4 (1), p.31-31

2008

Link zum Volltext

Verfügbarkeit prüfen

Local administration of N-acetylaspartylglutamate (NAAG) peptidase inhibitors is analgesic in peripheral pain in rats

The European journal of neuroscience, 2007-01, Vol.25 (1), p.147-158

2007

Link zum Volltext

Verfügbarkeit prüfen

Differential negative coupling of type 3 metabotropic glutamate receptor to cyclic GMP levels in neurons and astrocytes

Journal of neurochemistry, 2006-02, Vol.96 (4), p.1071-1077

2006

Link zum Volltext

Verfügbarkeit prüfen

Glutamate carboxypeptidase II gene knockout attenuates oxidative stress and cortical apoptosis after traumatic brain injury

BMC neuroscience, 2016-04, Vol.17 (15), p.15-15, Article 15

2016

Link zum Volltext

Verfügbarkeit prüfen

NAAG peptidase inhibitors and their potential for diagnosis and therapy

Nature reviews. Drug discovery, 2005-12, Vol.4 (12), p.1015-1026

2005

Link zum Volltext

Verfügbarkeit prüfen

mGluR3 and not mGluR2 receptors mediate the efficacy of NAAG peptidase inhibitor in validated model of schizophrenia

Schizophrenia research, 2012-04, Vol.136 (1), p.160-161

2012

Link zum Volltext

Verfügbarkeit prüfen

N-acetylaspartylglutamate : The most abundant peptide neurotransmitter in the mammalian central nervous system

Journal of neurochemistry, 2000-08, Vol.75 (2), p.443-452

2000

Link zum Volltext

Verfügbarkeit prüfen

NAAG Peptidase Inhibitors Act via mGluR3: Animal Models of Memory, Alzheimer’s, and Ethanol Intoxication

Neurochemical research, 2017-09, Vol.42 (9), p.2646-2657

2017

Link zum Volltext

Verfügbarkeit prüfen

Immunohistological and electrophysiological evidence that N-acetylaspartylglutamate is a co-transmitter at the vertebrate neuromuscular junction

The European journal of neuroscience, 2013-01, Vol.37 (1), p.118-129

2013

Link zum Volltext

Verfügbarkeit prüfen

The neurotransmitter N-acetylaspartylglutamate in models of pain, ALS, diabetic neuropathy, CNS injury and schizophrenia

Trends in pharmacological sciences (Regular ed.), 2005-09, Vol.26 (9), p.477-484

2005

Link zum Volltext

Verfügbarkeit prüfen

Group II mGluR agonist LY354740 and NAAG peptidase inhibitor effects on prepulse inhibition in PCP and d-amphetamine models of schizophrenia

Psychopharmacologia, 2011-07, Vol.216 (2), p.235-243

2011

Link zum Volltext

Verfügbarkeit prüfen

NAAG peptidase inhibitors and deletion of NAAG peptidase gene enhance memory in novel object recognition test

European journal of pharmacology, 2013-02, Vol.701 (1-3), p.27-32

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 200

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(196)
Mit Volltextzugriff
(177)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(152)
Life Sciences & Biomedicine
(134)
Animals
(81)
Neurosciences
(73)
Humans
(72)
Neurosciences & Neurology
(69)
Biological And Medical Sciences
(53)
Male
(49)
Rats
(39)
Fundamental And Applied Biological Sciences. Psychology
(36)
Medicin Och Hälsovetenskap
(32)
Biochemistry & Molecular Biology
(31)
Schizophrenia
(31)
Female
(30)
Vertebrates: Nervous System And Sense Organs
(28)
Genome-Wide Association Study
(26)
Mice
(26)
N-Acetylaspartylglutamate
(26)
Genetics & Heredity
(25)
Genetics
(24)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

N-acetylaspartylglutamate (NAAG) and glutamate carboxypeptidase II: An abundant peptide neurotransmitter-enzyme system with multiple clinical applications

Mice lacking glutamate carboxypeptidase II develop normally, but are less susceptible to traumatic brain injury

Advances in understanding the peptide neurotransmitter NAAG and appearance of a new member of the NAAG neuropeptide family

Endogenous N-Acetylaspartylglutamate (NAAG) Inhibits Synaptic Plasticity/Transmission in the Amygdala in a Mouse Inflammatory Pain Model

Parkin-mediated reduction of nuclear and soluble TDP-43 reverses behavioral decline in symptomatic mice

Effects of N-Acetylaspartylglutamate (NAAG) Peptidase Inhibition on Release of Glutamate and Dopamine in Prefrontal Cortex and Nucleus Accumbens in Phencyclidine Model of Schizophrenia

A role for N-acetylaspartylglutamate (NAAG) and mGluR3 in cognition

N‐Acetylaspartylglutamate is an agonist at mGluR3 in vivo and in vitro

Synthesis of Urea-Based Inhibitors as Active Site Probes of Glutamate Carboxypeptidase II: Efficacy as Analgesic Agents

A role for the locus coeruleus in the analgesic efficacy of N-acetylaspartylglutamate peptidase (GCPII) inhibitors ZJ43 and 2-PMPA

Design of Remarkably Simple, Yet Potent Urea-Based Inhibitors of Glutamate Carboxypeptidase II (NAALADase)

NAAG peptidase inhibitor increases dialysate NAAG and reduces glutamate, aspartate and GABA levels in the dorsal hippocampus following fluid percussion injury in the rat

Antinociceptive effects of N-acetylaspartylglutamate (NAAG) peptidase inhibitors ZJ-11, ZJ-17 and ZJ-43 in the rat formalin test and in the rat neuropathic pain model

Intracerebroventricular Administration of N-Acetylaspartylglutamate (NAAG) Peptidase Inhibitors is Analgesic in Inflammatory Pain

Local administration of N-acetylaspartylglutamate (NAAG) peptidase inhibitors is analgesic in peripheral pain in rats

Differential negative coupling of type 3 metabotropic glutamate receptor to cyclic GMP levels in neurons and astrocytes

Glutamate carboxypeptidase II gene knockout attenuates oxidative stress and cortical apoptosis after traumatic brain injury

NAAG peptidase inhibitors and their potential for diagnosis and therapy

mGluR3 and not mGluR2 receptors mediate the efficacy of NAAG peptidase inhibitor in validated model of schizophrenia

N-acetylaspartylglutamate : The most abundant peptide neurotransmitter in the mammalian central nervous system

NAAG Peptidase Inhibitors Act via mGluR3: Animal Models of Memory, Alzheimer’s, and Ethanol Intoxication

Immunohistological and electrophysiological evidence that N-acetylaspartylglutamate is a co-transmitter at the vertebrate neuromuscular junction

The neurotransmitter N-acetylaspartylglutamate in models of pain, ALS, diabetic neuropathy, CNS injury and schizophrenia

Group II mGluR agonist LY354740 and NAAG peptidase inhibitor effects on prepulse inhibition in PCP and d-amphetamine models of schizophrenia

NAAG peptidase inhibitors and deletion of NAAG peptidase gene enhance memory in novel object recognition test

Suchergebnisse filtern